These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The use of ribozyme gene therapy for the inhibition of HIV replication and its pathogenic sequelae. Rigden JE; Ely JA; Macpherson JL; Gerlach WL; Sun LQ; Symonds GP Curr Issues Mol Biol; 2000 Apr; 2(2):61-9. PubMed ID: 11471565 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line. Michienzi A; Conti L; Varano B; Prislei S; Gessani S; Bozzoni I Hum Gene Ther; 1998 Mar; 9(5):621-8. PubMed ID: 9551610 [TBL] [Abstract][Full Text] [Related]
7. Ribozymes in gene therapy of HIV-1. Macpherson JL; Ely JA; Sun LQ; Symonds GP Front Biosci; 1999 Jun; 4():D497-505. PubMed ID: 10352136 [TBL] [Abstract][Full Text] [Related]
8. Assessment of an anti-HIV-1 combination gene therapy strategy using the antisense RNA and multimeric hammerhead ribozymes. Ramezani A; Ma XZ; Ameli M; Arora A; Joshi S Front Biosci; 2006 Sep; 11():2940-8. PubMed ID: 16720366 [TBL] [Abstract][Full Text] [Related]
9. The potential use of catalytic RNAs in therapy of HIV infection and other diseases. Rossi JJ; Cantin EM; Sarver N; Chang PF Pharmacol Ther; 1991; 50(2):245-54. PubMed ID: 1763136 [TBL] [Abstract][Full Text] [Related]
10. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents. Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650 [TBL] [Abstract][Full Text] [Related]
11. The hairpin ribozyme: discovery, two-dimensional model, and development for gene therapy. Hampel A Prog Nucleic Acid Res Mol Biol; 1998; 58():1-39. PubMed ID: 9308362 [TBL] [Abstract][Full Text] [Related]
12. Ribozyme: a clinical tool. Khan AU Clin Chim Acta; 2006 May; 367(1-2):20-7. PubMed ID: 16426595 [TBL] [Abstract][Full Text] [Related]
13. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy. Bai J; Rossi J; Akkina R AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007 [TBL] [Abstract][Full Text] [Related]
14. Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents. Rossi JJ; Sarver N Adv Exp Med Biol; 1992; 312():95-109. PubMed ID: 1514448 [No Abstract] [Full Text] [Related]
15. Technology evaluation: HIV ribozyme gene therapy, Gene Shears Pty Ltd. de Feyter R; Li P Curr Opin Mol Ther; 2000 Jun; 2(3):332-5. PubMed ID: 11249628 [TBL] [Abstract][Full Text] [Related]